Cargando…
Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
BACKGROUND: Faecal immunochemical test (FIT)-directed pathways based on a single test have been implemented for symptomatic patients. However, with a single test, the sensitivity is 87 per cent at 10 µg haemoglobin (Hb) per g faeces. This aims of this study were to define the diagnostic performance...
Autores principales: | Gerrard, A D, Maeda, Y, Miller, J, Gunn, F, Theodoratou, E, Noble, C, Porteous, L, Glancy, S, MacLean, P, Pattenden, R, Dunlop, M G, Din, F V N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364540/ https://www.ncbi.nlm.nih.gov/pubmed/36785496 http://dx.doi.org/10.1093/bjs/znad016 |
Ejemplares similares
-
Author response to: Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Gerrard, Adam D, et al.
Publicado: (2023) -
Short‐term outcomes of a COVID‐adapted triage pathway for colorectal cancer detection
por: Miller, Janice, et al.
Publicado: (2021) -
Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Chong, Yuki, et al.
Publicado: (2023) -
Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing
por: Maeda, Y, et al.
Publicado: (2021) -
Impact of the faecal immunochemical test on colorectal cancer survival
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)